Brief: STADA And Xbrane Get British Approval For Ximluci (Ranibizumab) Biosimilar Referencing Lucentis

Xbrane Biopharma AB

17/01/2023 07:04

Jan 17 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * STADA AND XBRANE OBTAIN BRITISH APPROVAL FOR XIMLUCI®
(RANIBIZUMAB) BIOSIMILAR REFERENCING LUCENTIS®

Source text for Eikon:  ID:nMFN1py5rF 
Further company coverage:  XBRANE.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))